Sanmina saw the highest growth of 7.99% in patent filings in May and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 7.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Sanmina‘s patent filings and grants. Buy the databook here.
Sanmina has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 100% grants. The United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Sanmina is filings its patents. Among the top granted patent authorities, Sanmina has 100% of its grants in United States(US).
Samsung Group and Medtronic could be the strongest competitors for Sanmina
Patents related to healthtech and connected care lead Sanmina's portfolio
Sanmina has the highest number of patents in healthtech followed by, connected care and connected patient. For healthtech no patents were filed and 22% of patents were granted in Q2 2024.
Printed circuit manufacturing related patents lead Sanmina portfolio followed by drug delivery devices, and other remote patient monitoring
Sanmina has highest number of patents in printed circuit manufacturing followed by drug delivery devices, other remote patient monitoring, animal health & nutrition, and healthcare it.
For comprehensive analysis of Sanmina's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.